Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
2(50%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_4
1
25%
Ph not_applicable
3
75%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
3(75.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Completed(2)

Detailed Status

Recruiting2
Completed2

Development Timeline

Analytics

Development Status

Total Trials
4
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (25.0%)
N/A3 (75.0%)

Trials by Status

recruiting250%
completed250%

Recent Activity

2 active trials
Showing 4 of 4
recruitingphase_4

No More Sleepless Nights in Perimenopause

NCT06497894
completednot_applicable

A Feasibility Trial for Circadian Rest-activity Rhythm Disorders in Cancer (RALI)

NCT06329479
recruitingnot_applicable

Cognitive Behavioural Therapy for Insomnia in Patients With Coronary Heart Disease

NCT06749951
completednot_applicable

Effects of Group Cognitive Behavioural Therapy on Comorbid Insomnia and Depression in Youth

NCT03438331

Clinical Trials (4)

Showing 4 of 4 trials
NCT06497894Phase 4

No More Sleepless Nights in Perimenopause

Recruiting
NCT06329479Not Applicable

A Feasibility Trial for Circadian Rest-activity Rhythm Disorders in Cancer (RALI)

Completed
NCT06749951Not Applicable

Cognitive Behavioural Therapy for Insomnia in Patients With Coronary Heart Disease

Recruiting
NCT03438331Not Applicable

Effects of Group Cognitive Behavioural Therapy on Comorbid Insomnia and Depression in Youth

Completed

All 4 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
4